Screening of Frequent Donors of Blood and Blood Components
In October, the CBER published the draft guidance for industry "Implementation of Acceptable Abbreviated Donor History Questionnaire and Accompanying Materials for Use in Screening Frequent Donors of Blood and Blood Components". This guidance recognises the abbreviated donor history questionnaire and accompanying materials, version 1.3 dated August 2011. It was prepared by the AABB Donor History Task Force (referred to as “task force”) as an acceptable mechanism for collecting blood donor history information from frequent donors of blood and blood components that is consistent with the FDA requirements and recommendations.
The aDHQ (donor history questionnaires) documents will provide blood establishments collecting blood and blood components (referred to as “manufacturers” or “you”) with a specific process for administering questions to frequent donors of blood and blood components (referred to as “frequent blood donors”) to determine their eligibility to donate.
This guidance also recommends licensed manufacturers who choose to implement the acceptable aDHQ documents to report the manufacturing change consisting of the implementation of the aDHQ documents under 21 CFR 601.12 (§ 601.12).
Please see the complete draft guidance "Implementation of Acceptable Abbreviated Donor History Questionnaire and Accompanying Materials for Use in Screening Frequent Donors of Blood and Blood Components".
Author
Axel H. Schroeder
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years